Skip to main content

Advertisement

Log in

Which pain intensity scale from the Brief Pain Inventory correlates most highly with functional interference scores in patients experiencing taxane-induced arthralgia and myalgia?

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to assess which pain intensity dimension scale (worst, least, average, or current pain) from the Brief Pain Inventory (BPI) correlates most highly with functional interference scores in patients experiencing taxane-induced arthralgia and myalgia.

Methods

Breast cancer patients scheduled to receive docetaxel, paclitaxel, or albumin-bound paclitaxel (nab-paclitaxel) were enrolled in the study. Patients completed an initial baseline questionnaire and subsequently filled out a diary based on the BPI on days 1–7, 14, and 21 for three consecutive treatment cycles. Pain scores for worst, least, average, and current pain intensity dimensions as well as pain interference scores were recorded in the diaries and questionnaires using the BPI. Worst, least, average, and current pain scores were correlated with functional pain interference scores using Spearman’s rank correlation coefficients. A general linear mixed model of each functional interference measure was performed over time for cycles 1–3 with each pain intensity dimension scale.

Results

Among worst, average, least, and current joint pain dimensions, average joint pain scores correlated best with all BPI interference responses while average muscle pain scores correlated best with all BPI interference responses except for sleeping probability and normal work.

Conclusion

We recommend the BPI scale measuring average pain for future studies evaluating pain scores in patients experiencing taxane-induced arthralgia and myalgia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29(11):1472–1478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Saibil S, Fitzgerald B, Freedman OC, Amir E, Napolskikh J, Salvo N et al (2010) Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey. Curr Oncol 17(4):42

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Harris K, Li K, Flynn C, Chow E (2007) Worst, average or current pain in the brief pain inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases? Clin Oncol 19(7):523–527

    Article  CAS  Google Scholar 

  4. Jensen MP (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4(1):2–21

    Article  PubMed  Google Scholar 

  5. Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J (1999) Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgia and myalgia. Gynecol Oncol 72(1):100–101

    Article  CAS  PubMed  Google Scholar 

  6. Zelman DC, Hoffman DL, Seifeldin R, Dukes EM (2003) Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. Pain 106(1):35–42

    Article  PubMed  Google Scholar 

  7. Jensen MP (2003) Questionnaire validation: a brief guide for readers of the research literature. Clin J Pain 19(6):345–352

    Article  PubMed  Google Scholar 

  8. Jensen MP, Smith DG, Ehde DM, Robinsin LR (2001) Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 91(3):317–322

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the generous support of the Bratty Family Fund, Michael and Karyn Goldstein Cancer Research Fund, Joey and Mary Furfari Cancer Research Fund, Pulenzas Cancer Research Fund, Joseph and Silvana Melara Cancer Research Fund, and Ofelia Cancer Research Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward Chow.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Appendices

Appendix 1 Daily diary questionnaire

figure a

Appendix 2

Table 4 Linear mixed model of each BPI item on different pain scores over time (cycles 1–3)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiu, N., Zhang, L., Gallo-Hershberg, D. et al. Which pain intensity scale from the Brief Pain Inventory correlates most highly with functional interference scores in patients experiencing taxane-induced arthralgia and myalgia?. Support Care Cancer 24, 2979–2988 (2016). https://doi.org/10.1007/s00520-016-3106-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3106-5

Keywords

Navigation